Relative contribution of sensory and motor impairments to mobility limitations in children with cerebral palsy: an observational study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 02 2023
Historique:
received: 27 09 2022
accepted: 21 02 2023
entrez: 24 2 2023
pubmed: 25 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

The purpose of this study was to determine the relative contribution of sensory and motor impairments to mobility limitations in cerebral palsy. An observational study was carried out in 83 children with all types of cerebral palsy with a mean age of 10.8 years (SD 1.2). Five impairments (coordination, strength, spasticity, contracture, proprioception) and three aspects of mobility (standing up from a chair, short and long distance walking) were measured. Standard multiple regression was used to determine the relative contribution of impairments to mobility as well as the relative contribution of strength of individual muscle groups (dorsiflexors, plantarflexors, knee extensors, hip abductors and hip extensors) to mobility. Five impairments accounted for 48% of the variance in overall mobility (p < 0.001): coordination independently accounted for 9%, contracture for 4% and strength for 3% of the variance. Five muscle groups accounted for 53% of the variance in overall mobility (p < 0.001): hip extensors independently accounted for 9%, knee extensors for 4%, dorsiflexors for 4% and plantarflexors for 3% of the variance. Our findings demonstrate that the impairments making a significant independent contribution to mobility in pre-adolescent cerebral palsy were loss of coordination, loss of strength and contracture.

Identifiants

pubmed: 36828863
doi: 10.1038/s41598-023-30293-9
pii: 10.1038/s41598-023-30293-9
pmc: PMC9957987
doi:

Types de publication

Observational Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3229

Informations de copyright

© 2023. The Author(s).

Références

Health Qual Life Outcomes. 2018 Apr 19;16(1):70
pubmed: 29673348
J Gerontol A Biol Sci Med Sci. 2003 May;58(5):M453-60
pubmed: 12730256
Dev Med Child Neurol. 2004 Sep;46(9):580-9
pubmed: 15344517
J Pediatr Orthop. 2019 Sep;39(8):429-435
pubmed: 31393305
Phys Ther. 2003 Mar;83(3):237-52
pubmed: 12620088
Stroke Res Treat. 2012;2012:470648
pubmed: 22013550
Int J Environ Res Public Health. 2019 Nov 15;16(22):
pubmed: 31731636
J Gerontol A Biol Sci Med Sci. 2002 Aug;57(8):M539-43
pubmed: 12145369
Phys Ther. 2016 Dec;96(12):1938-1954
pubmed: 27313240
PLoS One. 2019 Oct 11;14(10):e0223363
pubmed: 31603897
Dev Med Child Neurol. 2009 Apr;51(4):295-302
pubmed: 19391185
Dev Med Child Neurol. 2009 Oct;51 Suppl 4:59-63
pubmed: 19740211
Arch Phys Med Rehabil. 2006 Aug;87(8):1091-9
pubmed: 16876555
Dev Med Child Neurol. 2011 Aug;53(8):704-10
pubmed: 21707596
Disabil Health J. 2016 Jul;9(3):375-84
pubmed: 27286912
Acta Orthop Traumatol Turc. 2011;45(6):421-4
pubmed: 22245818
Dev Med Child Neurol. 2006 Jul;48(7):549-54
pubmed: 16780622
Arch Phys Med Rehabil. 2014 Aug;95(8):1490-7
pubmed: 24681388
Arch Phys Med Rehabil. 2014 Feb;95(2):360-8
pubmed: 24231402
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):453-464
pubmed: 29392922
Cochrane Database Syst Rev. 2017 Jun 11;6:CD011660
pubmed: 28602046
Acta Cardiol Sin. 2015 May;31(3):193-201
pubmed: 27122870
Arch Phys Med Rehabil. 2005 May;86(5):993-8
pubmed: 15895347
Dev Med Child Neurol. 2014 Mar;56(3):245-51
pubmed: 24344767
Cochrane Database Syst Rev. 2020 Nov 18;11:CD013114
pubmed: 33202482
Dev Neurorehabil. 2020 Aug;23(6):343-348
pubmed: 31366265
Lancet. 2015 Feb 21;385(9969):705-16
pubmed: 25301503
Med Sci Sports Exerc. 2018 Aug;50(8):1549-1557
pubmed: 29557839
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Neurorehabil Neural Repair. 2017 Sep;31(9):827-841
pubmed: 28786309
Arch Phys Med Rehabil. 2000 Dec;81(12):1547-55
pubmed: 11128888
Dev Med Child Neurol. 2007 Sep;49(9):647-53
pubmed: 17718819
Braz J Phys Ther. 2015 Jul-Aug;19(4):311-9
pubmed: 26443979
Clin Rehabil. 2012 Jul;26(7):664-71
pubmed: 22080526
Dev Med Child Neurol. 2014 Mar;56(3):275-82
pubmed: 24127787

Auteurs

Hsiu-Ching Chiu (HC)

Department of Physical Therapy, I-Shou University, Kaohsiung, Taiwan, ROC. hsiuchingchiu@isu.edu.tw.

Louise Ada (L)

Discipline of Physiotherapy, The University of Sydney, Lidcombe, Australia.

Rong-Ju Cherng (RJ)

Institute of Allied Health Sciences and Department of Physical Therapy, College of Medicine, National Chung Kung University, Tainan, Taiwan, ROC.

Chiehfeng Chen (C)

School of Public Health, Taipei Medical University, Taipei, Taiwan, ROC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH